MELBOURNE, Australia and SAN FRANCISCO, July 30, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...
~ Revenues from Ordinary Activities up 470% and Revenues from Contracts with Customers from Continuing Operations up 722% to A$3.8 Million ~ ~ Annual General Meeting to be Held on Tuesday, November 18 ...
Appendix: Report of House Committee on foreign affairs (60th Cong., 2d sess. House. Rept. 2169)--English forts.--Report of Captain Edward Mott.--Notes on the archaeology of the Champlain valley by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback